Fibrosis–a common pathway to organ injury and failure
The DOI matches its Crossref record; 117 of the 118 references it cites were found in a registry or an index.
Abstract
Fibrosis is a consequence of the inflammatory response. When fibrotic tissue becomes excessive, it can have diverse pathophysiological effects on a number of organ systems. The mechanisms underlying fibrosis and approaches to therapy are reviewed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hepatocyte injury, apoptosis and necrosis promote a sterile inflammatory response. This includes activation of KCs to clear necrotic debris, recruitment of lymphocytes and bone-marrow-derived monocytes, extracellular matrix (ECM) remodelling, myofibroblast activation, angiogenesis, and hepatocyte regeneration and differentiation to replace lost hepatocytes.11,31,32”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [31]
In the citing paper
“Both receptors are independently involved in regulation of cell adhesion, differentiation, proliferation of myofibroblasts and migration of both myofibroblasts and macrophages.31”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [31]
Citations
Cites
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327
Massagué, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3434 · Cited by 3,128
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
Liaw, Y.-F., Sung, J. J. Y., Chow, W. C., Farrell, G., Lee, C.-Z., Yuen, H., Tanwandee, T., Tao, Q.-M., Shue, K., Keene, O. N., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033364 · Cited by 2,266
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Hinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M.-L., & Gabbiani, G. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070112 · Cited by 2,068
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
Research works printed but not linked: 1
- TORAFIC Investigators Group, 2011, Clin Ther, 33, 1204.e3
Cited by
Items 601–700 of 1,001
Ren, Z., Mao, X., Wang, S., & Wang, X. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17990 · Cited by 23
SGLT-2 inhibitors as novel treatments of multiple organ fibrosis
Hu, J.-P., Teng, J., Hui, S., & Liang, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29486 · Cited by 26
Identification of P-Rex1 as an anti-inflammatory and anti-fibrogenic target for pulmonary fibrosis
Liang, Q., Cheng, N., Zhang, G., Liang, Y., Qian, F., Wu, D., & Ye, R. D. (2016) · Scientific Reports · doi:10.1038/srep25785 · Cited by 25
Mahale, A. M., Fikri, F., Hati, K. A., Shahwan, S. A., Jadaan, I. A., Katan, H. A., Khandekar, R. B., Maktabi, A. M., & Edward, D. P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187506 · Cited by 22
Systemic inhibition of BMP1-3 decreases progression of CCl4-induced liver fibrosis in rats
Grgurević, L., Erjavec, I., Grgurević, I., Dumić-Čule, I., Brkljačić, J. M., Verbanac, D., Matijašić, M., Paljetak, H. Č., Novak, R., Plečko, M., et al. (2017) · Growth Factors · doi:10.1080/08977194.2018.1428966 · Cited by 24
Wermuth, P. J., & Jiménez, S. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196559 · Cited by 23
Phosphocreatine Attenuates Isoproterenol-Induced Cardiac Fibrosis and Cardiomyocyte Apoptosis
Dai, H., Chen, L., Gao, D., & Fei, A. (2019) · BioMed Research International · doi:10.1155/2019/5408289 · Cited by 22
Gilbert, H. T. J., & Swift, J. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.03.002 · Cited by 23
Substance P and fibrotic diseases
Peng, L., Agogo, G. O., Guo, J., & Yan, M. (2019) · Neuropeptides · doi:10.1016/j.npep.2019.101941 · Cited by 25
Wang, F., Wang, S., Zhang, Y., Li, K., Harris, R. C., Gore, J. C., & Zhang, M. (2019) · NMR in Biomedicine · doi:10.1002/nbm.4128 · Cited by 21
Sedentary behavior and kidney function in adults: a narrative review
Volaklis, K. A., Mamadjanov, T., & Meisinger, C. (2020) · Wiener klinische Wochenschrift · doi:10.1007/s00508-020-01673-2 · Cited by 24
Editorial: Organ Fibrosis: Triggers, Pathways, and Cellular Plasticity
Mutsaers, H. A. M., & Olinga, P. (2016) · Frontiers in Medicine · doi:10.3389/fmed.2016.00055 · Cited by 22
Rajendran, P., Alzahrani, A. M., Veeraraghavan, V. P., & Ahmed, E. A. (2021) · Toxins · doi:10.3390/toxins13110745 · Cited by 20
Xue, L., Li, X. O., Zhu, X., Zhang, J., Zhou, S., Tang, W., Chen, D., Chen, Y., Dai, J., Wu, M., et al. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113859 · Cited by 21
Li, R., Wang, C., Zhou, M., Liu, Y., Chen, S., Chai, Z., Huang, H., Zhang, K., Han, Z., Hua, G., et al. (2022) · Extracellular Vesicle · doi:10.1016/j.vesic.2022.100018 · Cited by 21
Protein-Bound Uremic Toxins in Senescence and Kidney Fibrosis
Yang, Y., Mihajlovic, M., & Masereeuw, R. (2023) · Biomedicines · doi:10.3390/biomedicines11092408 · Cited by 24
Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer
Schiavoni, G., Messina, B., Scalera, S., Memeo, L., Colarossi, C., Mare, M., Blandino, G., Ciliberto, G., Bon, G., & Maugeri‐Saccà, M. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05027-8 · Cited by 22
Zhang, P., Cui, W., Hankey, K. G., Gibbs, A. M., Smith, C. P., Taylor-Howell, C., Kearney, S. R., & MacVittie, T. J. (2015) · Health Physics · doi:10.1097/hp.0000000000000343 · Cited by 21
Targeting Metabolic Abnormalities to Reverse Fibrosis in Iatrogenic Laryngotracheal Stenosis
Murphy, M. K., Motz, K. M., Ding, D., Yin, L. X., Duvvuri, M., Feeley, M., & Hillel, A. (2017) · The Laryngoscope · doi:10.1002/lary.26893 · Cited by 18
Disentangling the fibrous microenvironment: designer culture models for improved drug discovery
Ort, C., Lee, W., Kalashnikov, N., & Moraes, C. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1822815 · Cited by 20
Liu, J., Yin, J., Chen, P., Liu, D., He, W., Li, Y., Li, M., Fu, X., Zeng, G., Guo, Y., et al. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00501-4 · Cited by 20
Pathophysiology of Urinary Tract Obstruction
Gulmi, F. A., & Felsen, D. (2018) · Wiley eBooks · doi:10.1002/9781119245193.ch8 · Cited by 20
Deletion of ASPP1 in myofibroblasts alleviates myocardial fibrosis by reducing p53 degradation
Li, S., Yang, M., Zhao, Y., Zhai, Y., Sun, C., Guo, Y., Zhang, X., Zhang, L., Tian, T., Yang, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52739-y · Cited by 23
Du, Y., Xiao, H., Wan, J., Wang, X., Li, T., Zheng, S., Feng, J., Ye, Q., Li, J., Li, G., et al. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4607 · Cited by 19
Collagen XII Regulates Corneal Stromal Structure by Modulating Transforming Growth Factor-β Activity
Sun, M., Koudouna, E., Cogswell, D., Avila, M. Y., Koch, M., & Espana, E. M. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.10.014 · Cited by 21
2-Methoxyestradiol Inhibits Radiation-Induced Skin Injuries
Kim, J.-H., Nam, J.-K., Kim, A., Park, M., Lee, H., Park, J., Kim, J., & Lee, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084171 · Cited by 23
Yao, M., Lian, D., Wu, M., Zhou, Y., Fang, Y., Zhang, S., Zhang, W., Yang, Y., Li, R., Chen, H., et al. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s414179 · Cited by 21
Pericytes and cardiac stem cells: Common features and peculiarities
Beltrami, A. P., & Madeddu, P. R. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.023 · Cited by 19
Cho, M., Park, J., Cho, S., Park, K., Chai, J. S., Son, H., Kim, S.-W., & Paick, J. (2018) · Asian Journal of Andrology · doi:10.4103/aja.aja_82_17 · Cited by 19
Chen, X., Ge, W., Dong, T., Hu, J., Chen, L., Fan, X., Gong, Y., & Zhou, H. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.01.017 · Cited by 20
Arnò, B., Galli, F., Roostalu, U., Aldeiri, B., Miyake, T., Albertini, A., Bragg, L., Prehar, S., McDermott, J. C., Cartwright, E. J., et al. (2019) · Journal of Cell Science · doi:10.1242/jcs.234948 · Cited by 21
Sitbon, Y. H., Kaźmierczak, K., Liang, J., Yadav, S. K., Veerasammy, M., Kanashiro‐Takeuchi, R. M., & Szczesna‐Cordary, D. (2020) · FEBS Journal · doi:10.1111/febs.15243 · Cited by 19
De la fibrogenèse à la fibrose : mécanismes physiopathologiques et présentations cliniques
Maria, A. T. J., Bourgier, C., Martinaud, C., Borie, R., Rozier, P., Rivière, S., Crestani, B., & Guilpain, P. (2020) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2020.01.002 · Cited by 19
Belkahla, H., Antunes, J. C., Lalatonne, Y., Sainte‐Catherine, O., Illoul, C., Journé, C., Jandrot‐Perrus, M., Coradin, T., Gigoux, V., Guénin, E., et al. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00887g · Cited by 19
Rebolledo, D. L., Acuña, M. J., & Brandan, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105234 · Cited by 20
Ramírez-Hernández, A. A., Velázquez-Enríquez, J. M., Santos-Álvarez, J. C., López-Martínez, A., Reyes-Jiménez, E., Torres, G., González-García, K., Vásquez-Garzón, V. R., & Baltiérrez‐Hoyos, R. (2022) · Cells · doi:10.3390/cells11040630 · Cited by 20
Xie, H., Lu, J. L., Zhu, Y., Meng, X., & Wang, R. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.07.020 · Cited by 19
Comparative proteomics of paired vocal fold and oral mucosa fibroblasts
Karbiener, M., Darnhofer, B., Frisch, M.-T., Rinner, B., Birner‐Gruenberger, R., & Gugatschka, M. (2017) · Journal of Proteomics · doi:10.1016/j.jprot.2017.01.010 · Cited by 20
Ferreira, T. P. T., Lima, J. G. M. E., Farias‐Filho, F. A., de Sá, Y. A. P. J., de Arantes, A. C. S., Guimarães, F. V., Carvalho, V. F., Hogaboam, C. M., Wallace, J. L., Martins, M. A., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00388 · Cited by 18
Cardiorenal Syndrome: Emerging Role of Medical Imaging for Clinical Diagnosis and Management
Lin, L., Zhou, C., Dekkers, I. A., & Lamb, H. J. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11080734 · Cited by 18
Periplaneta americana (Insecta: Blattodea) and organ fibrosis: A mini review
Zhou, X., Yang, M., Jin, J., Chen, J., & Li, Z. (2022) · Medicine · doi:10.1097/md.0000000000032039 · Cited by 18
Mechanisms and therapeutic strategies of extracellular vesicles in cardiovascular diseases
Li, Q., Feng, Q., Zhou, H., Lin, C., Sun, X., Ma, C., Sun, L., Guo, G., & Wang, D. (2023) · MedComm · doi:10.1002/mco2.454 · Cited by 18
Zaher, W., Rocca, D. G. D., Pannone, L., Bovéda, S., de Asmundis, C., Chierchia, G., & Sorgente, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051316 · Cited by 18
Zhang, A., Wang, J., Hu, Y., Qiu, Y., & Dong, C. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131982 · Cited by 24
Inhibition of glutaminase to reverse fibrosis in iatrogenic laryngotracheal stenosis
Tsai, H., Motz, K., Ding, D., Lina, I. A., Murphy, M. K., Benner, D., Feeley, M., Hooper, J. E., & Hillel, A. T. (2020) · The Laryngoscope · doi:10.1002/lary.28493 · Cited by 18
Proliferative ability and accumulation of cancer stem cells in oral submucous fibrosis epithelium
Xie, C., Feng, H., Zhong, L., Shi, Y., Wei, Z., Hua, Y., Ji, N., Li, J., Tang, Z., & Chen, Q. (2020) · Oral Diseases · doi:10.1111/odi.13347 · Cited by 18
Chen, Y., Zelnick, L. R., Wang, K., Katz, R., Hoofnagle, A. N., Becker, J. O., Hsu, C., Go, A. S., Feldman, H. I., Mehta, R. C., et al. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa057 · Cited by 20
Lombardi, F., Augello, F. R., Palumbo, P., Mollsi, E., Giuliani, M., Cimini, A., Cifone, M. G., & Cinque, B. (2021) · Nutrients · doi:10.3390/nu13030882 · Cited by 18
Different Patterns of Kidney Fibrosis Are Indicative of Injury to Distinct Renal Compartments
Tampe, D., Schridde, L., Korsten, P., Ströbel, P., Zeisberg, M., Hakroush, S., & Tampe, B. (2021) · Cells · doi:10.3390/cells10082014 · Cited by 18
Qian, H., & Chen, L. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112340 · Cited by 20
Jerala, M., Hauptman, N., Kojc, N., & Zidar, N. (2022) · Cells · doi:10.3390/cells11030314 · Cited by 19
Akahori, D., Inui, N., Inoue, Y., Yasui, H., Hozumi, H., Suzuki, Y., Karayama, M., Furuhashi, K., Enomoto, N., Fujisawa, T., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168996 · Cited by 20
Considerations for Clinical Trials Targeting the Myocardial Interstitium
Lewis, G. A., Dodd, S. R., Naish, J. H., Selvanayagam, J. B., Dweck, M. R., & Miller, C. (2019) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2019.03.034 · Cited by 20
Inflammation drives fibrotic scars in the CNS
Sofroniew, M. V. (2021) · Nature Neuroscience · doi:10.1038/s41593-020-00777-2 · Cited by 19
Qi, R., Jiang, J.-S., Shao, J., Zhang, Q., Zheng, K., Xiao, J., Huang, S., & Gong, S. (2022) · European Radiology · doi:10.1007/s00330-021-08514-4 · Cited by 17
Kumar, S., Fan, X., Rasouly, H. M., Sharma, R., Salant, D. J., & Lu, W. (2023) · JCI Insight · doi:10.1172/jci.insight.158418 · Cited by 18
TRPV4 regulates β 1 integrin‐mediated cell–matrix adhesions and collagen remodeling
Ji, C., Wang, Y., Wang, Q. L., Wang, A., Ali, A. A., & McCulloch, C. A. (2023) · The FASEB Journal · doi:10.1096/fj.202300222r · Cited by 19
Rabkin, S. W., & Wong, C. N. (2023) · Biomedicines · doi:10.3390/biomedicines11102815 · Cited by 17
LncRNAs: Proverbial Genomic “Junk” or Key Epigenetic Regulators During Cardiac Fibrosis in Diabetes?
Biswas, S., Thomas, A. A., & Chakrabarti, S. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00028 · Cited by 18
The roles of CyPA and CD147 in cardiac remodelling
Su, H., & Yang, Y. (2018) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2018.05.001 · Cited by 18
‘PARP’ing fibrosis: repurposing poly (ADP ribose) polymerase (PARP) inhibitors
Rao, P. D., Sankrityayan, H., Srivastava, A., Kulkarni, Y. A., Mulay, S. R., & Gaikwad, A. B. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.04.019 · Cited by 19
Extracellular Matrix and Cellular Plasticity in Musculoskeletal Development
Yan, S. K., Chan, A., Rubab, A., Chan, W. C. W., & Chan, D. T.-M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00781 · Cited by 20
Miyake, T., Sakai, N., Tamai, A., Sato, K., Kamikawa, Y., Miyagawa, T., Ogura, H., Yamamura, Y., Oshima, M., Nakagawa, S., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-71230-4 · Cited by 19
Ye, M., Zhao, F., Ma, K., Zhou, K., Ma, J., Fu, H., Xu, Z.-B., Huang, W., Wang, W., Zhao, J., et al. (2021) · Andrologia · doi:10.1111/and.14044 · Cited by 17
Cobalt exposure increases the risk of fibrosis of people living near E‑waste recycling area
Xue, K., Qian, Y., Wang, Z., Guo, C., Wang, Z., Li, X., Li, Z., & Wei, Y. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.112145 · Cited by 21
Sos1 Modulates Extracellular Matrix Synthesis, Proliferation, and Migration in Fibroblasts
Calvo, I. F., & Martínez‐Salgado, C. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.645044 · Cited by 17
Apilimod alters TGFβ signaling pathway and prevents cardiac fibrotic remodeling
Cinato, M., Guitou, L., Saidi, A., Timotin, A., Sperazza, E., Duparc, T., Zolov, S. N., Giridharan, S. S. P., Weisman, L. S., Martinez, L. O., et al. (2021) · Theranostics · doi:10.7150/thno.55821 · Cited by 20
Progressive Fibrosing Interstitial Lung Diseases: A Current Perspective
Albera, C., Verri, G., Sciarrone, F., Sitia, E., Mangiapia, M., & Solidoro, P. (2021) · Biomedicines · doi:10.3390/biomedicines9091237 · Cited by 17
FAM114A1 influences cardiac pathological remodeling by regulating angiotensin II signaling
Subbaiah, K. C. V., Wu, J., Tang, W. H. W., & Yao, P. (2022) · JCI Insight · doi:10.1172/jci.insight.152783 · Cited by 17
Quaife, N. M., Chothani, S. P., Schulz, J. F., Lindberg, E. L., Vanezis, K., Adami, E., O’Fee, K., Greiner, J., Litviňuková, M., van Heesch, S., et al. (2022) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-022-10288-z · Cited by 19
Xu, Z., He, B., Jiang, Y., Zhang, M., Tian, Y., Zhou, N., Zhou, Y., Chen, M., Tang, M., Gao, J., et al. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108987 · Cited by 20
Wang, J., Hu, Y., Han, Y., Fang, Q., Chen, Z., Wang, Y., Zhao, P., Wang, H., & Lin, Q. (2023) · Regenerative Biomaterials · doi:10.1093/rb/rbad020 · Cited by 17
Low-power laser irradiation inhibits arecoline-induced fibrosis: an in vitro study
Yeh, M.-C., Chen, K.-K., Chiang, M., Chen, C., Chen, P., Lee, H.-E., & Wang, Y. (2017) · International Journal of Oral Science · doi:10.1038/ijos.2016.49 · Cited by 17
Varma, V. K., Kajdacsy‐Balla, A., Akkina, S. K., Setty, S., & Walsh, M. J. (2018) · Scientific Reports · doi:10.1038/s41598-017-19006-1 · Cited by 17
Expression of neuropeptide Y is increased in an activated human HSC cell line
Dai, W., Liu, Y., Zhang, Y., Sun, Y., Sun, C., Zhang, Y., & Lv, X. (2019) · Scientific Reports · doi:10.1038/s41598-019-45932-3 · Cited by 20
Arai, Y., Chavkin, N. W., Arai, Y., Halvardson, J., Bjurling, J., Doviak, H., Cochran, J. D., Evans, M. A., Horitani, K., Yura, Y., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adv4071 · Cited by 17
Fibrosis in Immune-Mediated and Autoimmune Disorders
Żurawek, M., Ziółkowska‐Suchanek, I., & Iżykowska, K. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14186636 · Cited by 22
Role of sialidase Neu3 and ganglioside GM3 in cardiac fibroblasts activation
Ghiroldi, A., Piccoli, M., Creo, P., Cirillo, F., Rota, P., D’Imperio, S., Ciconte, G., Monasky, M. M., Micaglio, E., Garatti, A., et al. (2020) · Biochemical Journal · doi:10.1042/bcj20200360 · Cited by 16
Macrophages in intestinal fibrosis and regression
Yao, H., & Tang, G. (2022) · Cellular Immunology · doi:10.1016/j.cellimm.2022.104614 · Cited by 19
Noninvasive assessment of liver fibrosis and portal hypertension
Duarte‐Rojo, A., Patel, K., & Rockey, D. C. (2024) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000001019 · Cited by 18
Self-citationExploring the role of pericardial miRNAs and exosomes in modulating cardiac fibrosis
Schoettler, F. I., Hassanabad, A. F., Jadli, A. S., Patel, V. B., & Fedak, P. W. M. (2024) · Cardiovascular Pathology · doi:10.1016/j.carpath.2024.107671 · Cited by 18
Molecular prognostic prediction in liver cirrhosis
Goossens, N., Nakagawa, S., & Hoshida, Y. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i36.10262 · Cited by 16
Luca, M. D., Vecchie’, D., Athmanathan, B., Sreejit, G., Valcin, J. A., Swain, T. M., Sertié, R. A. L., Wekesa, K. S., Rowe, G. C., Bailey, S. M., et al. (2019) · Nutrients · doi:10.3390/nu11112810 · Cited by 17
Genetic Deletion of Polo-Like Kinase 2 Induces a Pro-Fibrotic Pulmonary Phenotype
Kant, T. A., Newe, M., Winter, L., Hoffmann, M., Kämmerer, S., Klapproth, E., Künzel, K., Kühnel, M., Neubert, L., El‐Armouche, A., et al. (2021) · Cells · doi:10.3390/cells10030617 · Cited by 17
Optical Detection of Distal Lung Enzyme Activity in Human Inflammatory Lung Disease
Megía-Fernández, A., Marshall, A. D. L., Akram, A. R., Mills, B., Chankeshwara, S. V., Scholefield, E., Miele, A., McGorum, B. C., Michaels, C., Knighton, N. J., et al. (2021) · BME Frontiers · doi:10.34133/2021/9834163 · Cited by 19
The potential regulatory role of BMP9 in inflammatory responses
Song, T., Huang, D., & Song, D. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2021.08.010 · Cited by 16
Eosinophilic esophagitis: novel concepts regarding pathogenesis and clinical manifestations
Sciumè, G. D., Visaggi, P., Sostilio, A., TARDUCCI, L., Pugno, C., Frazzoni, M., Ricchiuti, A., Bellini, M., Giannini, E. G., Marchi, S., et al. (2022) · Minerva Gastroenterology · doi:10.23736/s2724-5985.20.02807-x · Cited by 25
Canullo, L., Giuliani, A., Furlani, M., Menini, M., Piattelli, A., & Iezzi, G. (2023) · Clinical Oral Implants Research · doi:10.1111/clr.14118 · Cited by 16
Targeting the Gremlin– VEGFR2 axis – a promising strategy for multiple diseases?
Erdmann, R., Özden, C., Weidmann, J., & Schultze, A. (2015) · The Journal of Pathology · doi:10.1002/path.4544 · Cited by 16
To be EndMT or not to be, that is the question in pulmonary hypertension
Xiong, J. (2015) · Protein & Cell · doi:10.1007/s13238-015-0183-z · Cited by 16
In vitro and ex vivo anti-fibrotic effects of LY2109761, a small molecule inhibitor against TGF-β
Luangmonkong, T., Suriguga, S., Adhyatmika, A., Adlia, A., Oosterhuis, D., Suthisisang, C. C., de Jong, K. P., Mutsaers, H. A. M., & Olinga, P. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.07.001 · Cited by 19
Acupuncture attenuates renal interstitial fibrosis via the TGF‑β/Smad pathway
Zuo, Z., Huang, P., Jiang, Y., Zhang, Y., & Zhu, M. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10470 · Cited by 22
Wimborne, H., Takemoto, K., Woster, P. M., Rockey, D. C., Lemasters, J. J., & Zhong, Z. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.09.026 · Cited by 17
Self-citationThe Role of Prostaglandins as Major Inflammatory Mediators in Colorectal Cancer
Macia-Guardado, M., Lutz, V., Hengstschläger, M., & Dolznig, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412191 · Cited by 19
Investigational drugs for idiopathic pulmonary fibrosis
Varone, F., Montemurro, G., Macagno, F., Calvello, M., Conte, E. G., Intini, E., Iovene, B., Leone, P. M., Mari, P., & Richeldi, L. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1364361 · Cited by 15
The Function and Therapeutic Potential of lncRNAs in Cardiac Fibrosis
Nie, X., Fan, J., & Wang, D. W. (2023) · Biology · doi:10.3390/biology12020154 · Cited by 16
Ishiuchi, N., Nakashima, A., Maeda, S., Miura, Y., Miyasako, K., Sasaki, K., Uchiki, T., Sasaki, A., Nagamatsu, S., Nakao, N., et al. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03350-3 · Cited by 16
Mitophagy in fibrotic diseases: molecular mechanisms and therapeutic applications
Cui, X. T., Zhou, Z., Tu, H., Wu, J., Zhou, J. P., Yi, Q., Liu, O., & Dai, X. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1430230 · Cited by 21
Targeting cardiac fibrosis with Chimeric Antigen Receptor-Engineered Cells
Zhang, Q., Dai, J., Liu, T., Rao, W., Li, D., Gu, Z., Huang, L., Wang, J., & Hou, X. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05134-6 · Cited by 15
Kakutani, N., Takada, S., Nambu, H., Matsumoto, J., Furihata, T., Yokota, T., Fukushima, A., & Kinugawa, S. (2020) · Skeletal Muscle · doi:10.1186/s13395-020-00230-9 · Cited by 15
Metadata
- Authors
- Rockey, D. C., Bell, P. D., & Hill, J. A.
- Affiliations
- Medical University of South Carolina (US)
- The University of Texas Southwestern Medical Center (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-03-19
- Volume
- 372
- Issue
- 12
- Pages
- 1138-1149
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1977437151
- Cited by
- 1,428
- References
- 118
- Citations by year
- 2026: 104 · 2025: 116 · 2024: 154 · 2023: 149 · 2022: 162 · 2021: 162 · 2020: 152 · 2019: 118 · 2018: 96 · 2017: 94 · 2016: 85 · 2015: 33
- FWCI
- 14.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- fibrosis, organ damage, organ failure, inflammation, fibrosis mechanisms, fibrosis treatment
- MeSH terms
- Fibrosis, Humans, Multiple Organ Failure, Transforming Growth Factor beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.